• Mashup Score: 0

    February 17, 2023 — Allegheny Health Network’s (AHN) Cardiovascular Institute reached a significant milestone in cardiac transplantation when heart failure specialists and cardiothoracic surgeons, led by Candice Lee, MD, performed the 500th heart transplant at Allegheny General Hospital (AGH) in Pittsburgh on Saturday, January 14. The patient, Keith Lowry, 68, of Dunbar, Pa is recovering well…

    Tweet Tweets with this article
    • @DAICeditor #AlleghenyHealthNetwork’s (#AHN) #CardiovascularInstitute reached a significant #milestone in #cardiac_transplantation when #heartfailure specialists and #cardiothoracic #surgeons performed the 500th #hearttransplant at AGH in Pittsburgh: https://t.co/F6vPinnP8j

  • Mashup Score: 0

    December 22, 2022 — Acutus Medical, Inc., an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, announced that the company has achieved the second milestone under the asset purchase agreement with Medtronic of its left-heart access portfolio with the submission for CE Mark of this portfolio under European Union (EU) Medical Device Regulations…

    Tweet Tweets with this article
    • @DAICeditor @AcutusMedical @Medtronic Acutus has achieved the second #milestone under the asset purchase agreement with Medtronic of its #left_heart access portfolio with the submission for #CEMark of this portfolio under #EU_MDR: https://t.co/NwsGWLXH9K

  • Mashup Score: 0
    Homepage - 3 year(s) ago

    E²-RADIatE THE PLATFORM FOR RADIOTHERAPY E²-RADIatE (EORTC 1811 study) is a platform that collects real-world data through prospective data registries in radiotherapy. A collaboration between the European Organisation for Research and Treatment of Cancer (EORTC) and the European Society for Radiotherapy and Oncology (ESTRO), it aims to be a pan-European infrastructure and a

    Tweet Tweets with this article
    • New #milestone: 500 patients enrolled for #OligoCare More information about this registry project for patients with oligometastatic disease: https://t.co/2ZnEZJIGOb #radonc #CancerResearch @piet_ost @Mat_Guc @ESTRO_RT https://t.co/MjByCsiF7m